In order for our site to display correctly you will need a newer version of your web browser.
The following browsers support numerous web standards including CSS,XHTML, and the DOM (a universal means of controlling the behavior of web pages):
- Netscape v7 or higher (all platforms), Mozilla FireFox (Windows), Camino (Mac OS X), Galeon (Linux GNOME Desktop) or other browser stemming from the Mozilla.org project.
- Opera v7 or higher (Windows, Linux)
- Apple's Safari (Mac OS X)
- Konqueror (Linux KDE Desktop)
- Microsoft Internet Explorer v6 or higher (Windows) or v5 or higher (Macintosh)
Please note that this is not intended be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Finding Cures. Saving Children.
Jonathan A. McCullers, MD
Associate Member, St. Jude Faculty
Departments
Infectious Diseases
Contact Information
Jonathan McCullers, MD
Infectious Diseases
MS 320, Room E-8006
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: jon.mccullers@stjude.org
Phone: (901) 595-3486
FAX: (901) 595-3099
Education
MD - University of Alabama at Birmingham
Research Interests
- Influenza viruses
- Viral-bacterial synergism
Selected Publications
Karlström Å, Boyd KL, English BK, McCullers JA. Treatment with protein synthesis inhibitors improves outcomes from secondary bacterial pneumonia following influenza. J Inf Dis 199(3), 311-9, 2009.
Huber VC, Thomas PG, McCullers JA. A Multi-valent Vaccine Approach That Elicits Broad Immunity Within an Influenza Subtype. Vaccine 27, 1192-1200, 2009.
McCullers JA, English BK. Improving therapeutic strategies for secondary bacterial pneumonia following influenza. Fut Microb 3(4), 397-404, 2008.
Huber VC, McCullers JA. Vaccines against pandemic influenza; what can be done before the next pandemic? Ped Inf Dis J 27, S113-7, 2008.
Huber VC, Kleimeyer LH, McCullers JA. Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus. Vaccine 26(42), 5381-8, 2008.
McAuley J, Horning F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell J, McCullers JA. The 1918 PB1-F2 protein contributes to virulence and immunopathology of primary viral and secondary bacterial infections. Cell Host Microbe 2, 240-9, 2007.
McCullers JA, Karlstrom A, Iverson AR, Loeffler J, Fischetti VA. A novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLOS Pathogens 3(3), e28, 2007.
Vigerust DJ, Ulett KB, Madsen J, Hawgood S, McCullers JA. N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 81(16), 8593-600, 2007.
Huber VC, McCullers JA. Live Attenuated Influenza Vaccine is Safe and Immunogenic in Immunocompromised Ferrets. J Infect Dis 193(5), 677-84, 2006.
Huber VC, McKeon RM, Brackin MN, Miller LA, Keating R, Brown SA, Makarova NI, Perez DR, MacDonald G, McCullers JA. Distinct roles for IgG1 and IgG2a antibodies in the development of DNA and viral replicon particle-based influenza vaccines. Clin Vacc Immunol 13(9), 981-90, 2006.
Peltola VT, Boyd KL, McAuley JL, Rehg J, McCullers JA. Bacterial sinusitis and otitis media in ferrets following influenza. Infect Immun 74(5), 2562-7, 2006.
McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Micro Rev 19(3), 571-82, 2006.
Peltola VT, Murti KG, McCullers JA. The influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Inf Dis 192, 249-257, 2005.
McCullers JA. Antiviral treatment impacts the outcome of secondary bacterial pneumonia following influenza. J Infect Dis 190, 519-526, 2004.
McCullers JA, Bartmess KC. Role of the viral neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 187(6), 1000-9, 2003.
Last update: April 2009
